Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Bouchard

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Physics in Medicine and Biology|May 3, 2019
Influence of intravenous contrast agent on dose calculation in proton therapy using dual energy CTArthur Lalonde, Yunhe Xie, Brendan Burgdorf, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapyStéphane Potvin, Edouard Kouassi, Olivier Lipp, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 20, 2020
Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychoticsMarc-André Nolin, Marie-France Demers, Chloé Rauzier, et al.
The Journal of Nervous and Mental Disease|December 8, 2004
A factor analysis of the Strauss and Carpenter revised outcome criteria scale: a validation of the French translationSimon Poirier, Véronique Bureau, Catherine Lehoux, et al.
Schizophrenia Bulletin|April 23, 2010
Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectoriesMichel Maziade, Nancie Rouleau, Chantal Mérette, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Physics in Medicine and Biology|May 3, 2019
Influence of intravenous contrast agent on dose calculation in proton therapy using dual energy CTArthur Lalonde, Yunhe Xie, Brendan Burgdorf, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapyStéphane Potvin, Edouard Kouassi, Olivier Lipp, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 20, 2020
Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychoticsMarc-André Nolin, Marie-France Demers, Chloé Rauzier, et al.
The Journal of Nervous and Mental Disease|December 8, 2004
A factor analysis of the Strauss and Carpenter revised outcome criteria scale: a validation of the French translationSimon Poirier, Véronique Bureau, Catherine Lehoux, et al.
Schizophrenia Bulletin|April 23, 2010
Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectoriesMichel Maziade, Nancie Rouleau, Chantal Mérette, et al.
Pageof 9